Literature DB >> 16505234

Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance.

Juan C Molero1, Samuel G Waring, Adrian Cooper, Nigel Turner, Ross Laybutt, Gregory J Cooney, David E James.   

Abstract

Casitas b-lineage lymphoma (c-Cbl) is a multiadaptor protein with E3-ubiquitin ligase activity involved in regulating the degradation of receptor tyrosine kinases. We have recently reported that c-Cbl(-/-) mice exhibit a lean phenotype and enhanced peripheral insulin action likely due to elevated energy expenditure. In the study reported here, we examined the effect of a high-fat diet on energy homeostasis and glucose metabolism in these animals. When c-Cbl(-/-) mice were fed a high-fat diet for 4 weeks, they maintained hyperphagia, higher whole-body oxygen consumption (27%), and greater activity (threefold) compared with wild-type animals fed the same diet. In addition, the activity of several enzymes involved in mitochondrial fat oxidation and the phosphorylation of acetyl CoA carboxylase was significantly increased in muscle of high-fat-fed c-Cbl-deficient mice, indicating a greater capacity for fat oxidation in these animals. As a result of these differences, fat-fed c-Cbl(-/-) mice were 30% leaner than wild-type animals and were protected against high-fat diet-induced insulin resistance. These studies are consistent with a role for c-Cbl in regulating nutrient partitioning in skeletal muscle and emphasize the potential of c-Cbl as a therapeutic target in the treatment of obesity and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505234     DOI: 10.2337/diabetes.55.03.06.db05-0312

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  Transgenic mouse models resistant to diet-induced metabolic disease: is energy balance the key?

Authors:  Laura A A Gilliam; P Darrell Neufer
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

Review 2.  Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field.

Authors:  Natasha Dave; Jiao Wu; Sandhya Thomas
Journal:  Curr Diab Rep       Date:  2018-06-08       Impact factor: 4.810

3.  Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake.

Authors:  Sabeera Bonala; Sudarsanareddy Lokireddy; Craig McFarlane; Sreekanth Patnam; Mridula Sharma; Ravi Kambadur
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

4.  Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target.

Authors:  Xiao-Yi Zeng; Hao Wang; Fang Bai; Xiu Zhou; Song-Pei Li; Lu-Ping Ren; Ruo-Qiong Sun; Charlie C L Xue; Hua-Liang Jiang; Li-Hong Hu; Ji-Ming Ye
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

5.  Nedd4 haploinsufficient mice display moderate insulin resistance, enhanced lipolysis, and protection against high-fat diet-induced obesity.

Authors:  Jing Jing Li; Robert J Ferry; Shiyong Diao; Bingzhong Xue; Suleiman W Bahouth; Francesca-Fang Liao
Journal:  Endocrinology       Date:  2015-01-21       Impact factor: 4.736

6.  Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation.

Authors:  Andrew J Hoy; Amanda E Brandon; Nigel Turner; Matthew J Watt; Clinton R Bruce; Gregory J Cooney; Edward W Kraegen
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-04-14       Impact factor: 4.310

7.  Lipid-induced mitochondrial stress and insulin action in muscle.

Authors:  Deborah M Muoio; P Darrell Neufer
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

8.  Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis.

Authors:  Ayumi Sato; Hiroyuki Kawano; Tatsuto Notsu; Masahiko Ohta; Masanori Nakakuki; Kiyoshi Mizuguchi; Michiko Itoh; Takayoshi Suganami; Yoshihiro Ogawa
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461

9.  Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.

Authors:  Lu-Ping Ren; Stanley M H Chan; Xiao-Yi Zeng; D Ross Laybutt; Tristan J Iseli; Ruo-Qiong Sun; Edward W Kraegen; Gregory J Cooney; Nigel Turner; Ji-Ming Ye
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

10.  Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.

Authors:  Stanley M H Chan; Ruo-Qiong Sun; Xiao-Yi Zeng; Zi-Heng Choong; Hao Wang; Matthew J Watt; Ji-Ming Ye
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.